Drug responseDRUG → MUTATIONCell lineCT 99021, CHIR99021, CHIR 99021
Across CCLE and GDSC cell-line panels, response to CHIR-99021 is significantly associated with the mutation status of multiple genes, with LUNG_SCLC cell lines showing a particularly strong set of associations.
The most reproducible CHIR-99021 response-associated genes across cancer lineages are HMCN1, RANBP2, and PAK5, each associated with drug response in up to 1 lineages. Since the analysis identifies associations rather than directional relationships, both response-to-biomarker and biomarker-to-response views are provided.
Each biomarker is linked to its corresponding Q-omics profile. The box plot shows the strongest observed association, CHIR-99021 response grouped by HMCN1 status in LUNG_SCLC.
Mutation status biomarkers of CHIR-99021 response
Ranked by combined sampling and lineage consensus. X-score (response→biomarker) and Y-score (biomarker→response) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.